concept · intermediate · partly written
Alternative start codons and two protein forms
Ribosomes can start a protein at a different place than the first AUG, so one message can give two N-terminal forms; this is real but usually minor, and differs from his idea.
Also called: non-AUG initiation, alternative translation initiation, leaky scanning, start-loss, N-terminally truncated isoform, upstream open reading frame
His idea, kept as he said it
He said you may get two start codons, and so two versions of the protein; he also mentioned a reverse truncation. Kept in his words and not used as evidence. 1
Amit's hypothesis
What is real more
Leaky scanning, non-AUG starts and upstream open reading frames are documented. MYC has a CUG-initiated longer form, PTEN has an upstream AUU-initiated form (PTEN-beta), and MRPL18 shifts under stress to a downstream CUG start that drops the mitochondrial targeting signal. POLG carries an overlapping CUG-initiated reading frame (ORF-Y); 41 ClinVar variants that are synonymous for POLG change that second frame, many labelled benign, and the authors propose re-evaluation. That shows alternative starts can overlap annotated coding sequence; it is not a clinical start-loss case. 234
Reported, not yet replicated
What the dictation gets wrong more
First, the second start is usually a near-cognate codon and far less efficient than AUG, so the longer or shorter form is normally minor. Second, it is not a variant that creates two versions: one message usually gives both forms in the normal case. Third, a start-loss variant removes the first start, and whether the next in-frame AUG then rescues part of the protein is not shown by the sources opened. Fourth, reverse truncation is not a documented category in any opened source. A downstream-start fragment was seen in CCHCR1 transcripts that carry nonsense variants, from ribosome profiling in reporter constructs in human cells; that is evidence of initiation, not of a working protein. 35
Reported, not yet replicated
Start-loss in the clinic more
Two start-loss variants are opened. HNF1A c.2T>C (p.Met1Thr) is classified Pathogenic by an expert panel (2022) for monogenic diabetes, and its record carries both a missense and an initiator-codon label, a naming trap. PAH c.3G>A (p.Met1Ile) is Pathogenic for recessive phenylketonuria; the classification applied the strong null-variant criterion, noted no known alternative start codons, and found the next in-frame methionine at amino acid 180. The general ClinGen rule is weaker: it generally does not recommend the full null-variant criterion for start-loss, giving moderate strength if pathogenic variants lie upstream of the next in-frame methionine and supporting strength otherwise, and none if an alternative transcript starts elsewhere. So full strength for PAH is a disease-specific panel choice. 678
Reported, not yet replicated
Scale: footprints against peptides more
Footprint-called starts number in the thousands (13,454 in mouse embryonic stem cells; 7,251 in human THP-1 cells). Protein-level proof is smaller: in Jurkat cells N-terminal proteomics found 443 alternative N-termini among 2,578 peptides (133 genes with two or more N-termini), and ribosome profiling agreed with 89% of annotated starts but 29% of alternative ones. The alternative form is the lesser one in every case with a number. The 'about 60% of initiation events at non-AUG sites' figure in this record counts sites, not efficiency-weighted events; see concepts/translation-initiation-and-start-codon-choice for the full account. 91011
Reported, not yet replicated
Plain answer
A scanning ribosome can skip a weak start site and start further along, or start at a near-match to AUG such as CUG, GUG or AUU. One message can then give two proteins with different beginnings. Documented cases exist (MYC, PTEN, MRPL18), but the alternative start is usually far less efficient than AUG, so the second form is normally the minor one. 32
Reported, not yet replicated
Why it matters
Variant classification has to decide what a start-loss variant (one that destroys the first AUG) does: lose the protein, or let a downstream start rescue part of it. The clinical rule is conservative for that reason. 8
Reported, not yet replicated
Real numbers
Messages with an upstream AUG
About 56 to 58% of human messages carry an upstream AUG. 2
Reported, not yet replicated
Share of initiation at non-AUG sites
About 60% of initiation events occur at non-AUG sites, but most protein still comes from AUG. 3
Reported, not yet replicated
Still open here
- No opened patient case shows a downstream start rescuing part of a protein after a start-loss variant. Leads (SLC26A4, LAMA2, GRN, ATM) came from an aggregator and are unverified.
- The 85% and 57% of nonsense variants with an in-frame methionine within 50 codons (from a review the source check could not re-open) are not quoted.
Not yet written: Equation.
Linked from
- Ribosome profiling (Ribo-seq)
- Protein targeting, translocation, quality control at the ribosome and degradation
- Splicing
- Translation initiation: scanning and start-codon choice
- Stop-gain variants that escape nonsense-mediated decay
- For how many human genes does a second start codon make a second protein with its own job?
Sources
- Amit's dictation of 2026-11-17: what the atlas must contain. Kept in the atlas repository; not published.
- Andreev DE, Loughran G, Fedorova AD, et al.. Non-AUG translation initiation in mammals. Genome Biol (2022). review; opened 2026-11-17 all records citing this
- Kearse MG, Wilusz JE. Non-AUG translation: a new start for protein synthesis in eukaryotes. Genes Dev (2017). review; opened 2026-11-17 all records citing this
- Khan, Y., Jungreis, I., Wright, J., et al.. Evidence for a novel overlapping coding sequence in POLG initiated at a CUG start codon. BMC Genetics (2020). paper; opened 2026-11-17 all records citing this
- Jagannathan S, Bradley RK. Translational plasticity facilitates the accumulation of nonsense genetic variants in the human population. Genome Res (2016). paper; opened 2026-11-17 all records citing this
- NCBI ClinVar. ClinVar record 1342949: HNF1A c.2T>C (p.Met1Thr). ClinVar. database, not peer reviewed; opened 2026-11-17 all records citing this
- ClinGen. ClinGen evidence repository: PAH c.3G>A (p.Met1Ile) classification. ClinGen Evidence Repository. database, not peer reviewed; opened 2026-11-17 all records citing this
- Abou Tayoun AN, Pesaran T, DiStefano MT, et al.. Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat (2018). paper; opened 2026-11-17 all records citing this
- Ingolia NT, Lareau LF, Weissman JS. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes.. Cell (2011). paper; opened 2026-11-17 all records citing this
- Fritsch C, Herrmann A, Nothnagel M, et al.. Genome-wide search for novel human uORFs and N-terminal protein extensions using ribosomal footprinting.. Genome Res (2012). paper; opened 2026-11-17 all records citing this
- Gawron D, Ndah E, Gevaert K, et al.. Positional proteomics reveals differences in N-terminal proteoform stability.. Mol Syst Biol (2016). paper; opened 2026-11-17 all records citing this
Where it sits on the map
History of this record (3)
This record has been changed 3 times, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.
- Status
- partly written
- Last updated
- 2026-11-18
- Record
- content/concepts/alternative-start-codons.json